Brief: Oasmia: European Patent Office To Grant Xmena Patent
March 24 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* EUROPEAN PATENT OFFICE INFORMS OASMIA OF ITS INTENTION TO GRANT XMENA PATENT
* XMENA PATENT PROTECTS AN IMPROVED METHOD FOR MANUFACTURING PROCESS FOR OASMIA'S
NANOTECHNOLOGY
PLATFORM XR-17
Source text for Eikon: ID:nMFN9jQ7Tp
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO